ENGENE
enGene is a developer of a mucosal immunotherapy platform designed to treat inflammatory bowel disease and diabetes. The company's mucosal immunotherapy platform has developed a flexible nucleotide delivery technology targeting mucosal tissues to treat numerous prevalent, chronic diseases via the induction or suppression of protein expression levels, enabling physicians and doctors to regenerate physiologic, meal-regulated insulin secretion from the gut of subjects with diabetes.
ENGENE
Social Links:
Industry:
Biotechnology Diabetes Genetics Health Care
Founded:
1999-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.engene.com
Total Employee:
51+
Status:
Active
Contact:
604-221-4362
Email Addresses:
[email protected]
Total Funding:
33.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Content Delivery Network Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail ReCAPTCHA
Similar Organizations
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Investors List
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Grant - enGene
Lumira Ventures
Lumira Ventures investment in Venture Round - enGene
Forbion Capital Partners
Forbion Capital Partners investment in Series B - enGene
Lumira Ventures
Lumira Ventures investment in Series B - enGene
Inbio Ventures
Inbio Ventures investment in Series B - enGene
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Series B - enGene
Pharmstandard
Pharmstandard investment in Series B - enGene
Lumira Ventures
Lumira Ventures investment in Venture Round - enGene
RBC Capital Markets
RBC Capital Markets investment in Series A - enGene
Adams, Harkness & Hill Technology Ventures
Adams, Harkness & Hill Technology Ventures investment in Series A - enGene
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-17 | enGene Appoints James C. Sullivan, PhD as Chief Scientific Officer |
Official Site Inspections
http://www.engene.com Semrush global rank: 7.57 M Semrush visits lastest month: 458
- Host name: 79.1.212.35.bc.googleusercontent.com
- IP address: 35.212.1.79
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
